This Pre-Solicitation opportunity from Department Of Defense was posted on May 27, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Notice of Intent to Sole Source Cost-Per-Result-Reportable Automated Hematology Analyzer System for Naval Medical Center Portsmouth
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Government intends to award a sole source Firm-Fixed-Price contract to Sysmex America, Inc. for a Commercial-Off-The-Shelf Cost-Per-Result-Reportable Automated Hematology Analyzer System to be implemented at Naval Medical Center Portsmouth, Virginia. The system, specifically the XN-9100-202 model, is the only available technology that employs fluorescent flow cytometry to analyze RNA and DNA content and intracellular structures, enabling superior differentiation of white blood cell populations and accurate detection of immature and abnormal cells such as blasts, atypical lymphocytes, and immature granulocytes. This capability significantly enhances flagging accuracy, reduces the need for manual smear reviews, and supports earlier clinical decision-making, directly improving patient care quality and safety. The system also includes a proprietary RU 20 reagent dilution unit that minimizes diluent changes, reduces inventory and storage demands, and increases operational efficiency—critical factors given the laboratory’s constrained space due to ongoing renovation delays and undermanned staffing. The contract includes a base year running from July 1, 2026, to June 30, 2027, with four optional one-year periods and one optional six-month extension, bringing the total potential performance period to approximately six and a half years. The estimated contract value is $1,891,450, with annual base and option year costs of $343,900 and the final six-month extension priced at $171,950. The equipment will be delivered and maintained under a CPRR agreement covering the lease of duplicate hematology analyzers, automation line, advanced RBC and body fluid software, five concurrent &Teams Edition licenses, consumables, reagents, maintenance, spare parts, middleware integration, training, technical support, printers, and uninterruptible power supplies. All components must comply with FDA regulations, maintain a bidirectional interface with MHS Genesis and HL7/TCP/IP protocols, and adhere to OSHA safety standards. The system must be installed, operated, and supported within specified business hours and under strict security protocols including DBIDS identification, safeguarding of government property, and isolation of IT infrastructure for network compliance. Market research confirms Sysmex America, Inc. holds a valid Federal Supply Schedule contract through August 31, 2029, and no alternative vendor provides the same technological capabilities. This sole source determination is subject to review based on responses demonstrating clear and convincing evidence that competition would
General Info
Agency
NAICS
Place of Performance
Portsmouth, VA, 23708, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
The Government hereby submits a notice of intent to award a sole source Firm-Fixed-Price contract to Sysmex America, INC. for commercial-off-the-shelf (COTS) Cost-Per-Result-Reportable (CPRR) Automated Hematology Analyzer System. The contract will consist of a base year and four (4) option years, and one (1) Optional six (6) Month Option; the period of performance for the base year is 01July2026 - 30June2027. Sysmex America, INC.'s XN-9100-202 is the only source available that utilizes fluorescent flow cytometry, which analyzes RNA and DNA content and intracellular cellular structures rather than relying solely on impedance and light scatter. This technology provides superior differentiation of white blood cell populations and improves identification of immature and abnormal cells, including blasts, atypical lymphocytes, and immature granulocytes. These capabilities support higher flagging accuracy, reduced manual smear reviews, and earlier clinical decision-making, directly impacting patient care quality and safety. Another feature is the RU 20 reagent dilution unit that has reduced diluent changes, inventory and storage. The RU is unique to Sysmex and offered by no other vendor. These features not only reduce the manual workload on minimal undermanned laboratory staff and minimal storage area needed, but increases, accuracy, efficiency, and readiness for regulatory audits within space constraints due to delays in renovation for NMCP’s laboratory. The total estimated value is $1,891,450.00. Market research has determined that Sysmex America, INC. has a strategically sourced Federal Supply Schedule contract V797D-40235 for CPRR Automated Hematology Analyzer System which is valid through 31August2029. Responses to this notice must demonstrate clear and convincing evidence that competition would be advantageous to the Government, would not be cost or time prohibitive, and would not hinder the mission objective of Naval Medical Center Portsmouth. The determination not to compete this proposed contract action is solely within the discretion of the Government. Information received will normally be considered for the purposes of determining whether to conduct a competitive procurement. The Government will not be responsible for any costs incurred by responding to this notice. This is not a request for quote or proposals. Questions or comments to this Notice of Intent should be directed to Contract Specialist, Lisa Wilk at lisa.c.wilk.civ@health.mil and Contract Officer, Carol Uebelacker at carol.e.uebelacker.civ@health.mil. Please indicate in the subject of your email: Notice of Intent Question Submission 12374114.
More opportunities from Department Of Defense → Defense Health Agency
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS